°­Àç½Â

  • Áø·á°ú

    °£´ãÃé¿Ü°ú

  • Àü¹®Áø·áºÐ¾ß

    ´ã³¶Áúȯ, ´ãµµÁúȯ, ÃéÀå¾Ï, ´ãµµ¾Ï, ´ã³¶¾Ï, ¹ÙÅÍÆØ´ëºÎ¾Ï, ÃéÀ島¼ºÁúȯ, ·Îº¿¼ö¼ú(ÃéÀå,´ã³¶,´ãµµ)

  • ´ã´çŬ¸®´Ð

  • °ü·Ã¼¾ÅÍ

    ÃéÀå¾Ï ¼¾ÅÍ , ´ãµµ¡¤´ã°ü¾Ï ¼¾ÅÍ

°­Àç½Â

°­Àç½Â ±³¼öÀÇ Áø·á½Ã°£Ç¥ Áø·á¿¹¾à

Áø·á°ú/¼¾ÅÍ ¿ù È­ ¼ö ¸ñ ±Ý Åä Àü¹®Áø·á°ú¸ñ
°£´ãÃé¿Ü°ú
¿ÀÀü
-
¿ÀÀü
- - - ´ã³¶Áúȯ, ´ãµµÁúȯ, ÃéÀå¾Ï, ´ãµµ¾Ï, ´ã³¶¾Ï, ¹ÙÅÍÆØ´ëºÎ¾Ï, ÃéÀ島¼ºÁúȯ, ·Îº¿¼ö¼ú(ÃéÀå,´ã³¶,´ãµµ)

°­Àç½Â ±³¼öÀÇ »ó¼¼Á¤º¸

ÇзÂ

more
  • 2005 .03  ~  2011 .02  :  ÇѸ²´ëÇб³ ÀÇ°ú´ëÇÐ Á¹¾÷
  • 2016 .09  ~  2018 .08  :  °­¿ø´ëÇб³ ´ëÇпø ÀÇÇаú ¼®»ç
  • 2020 .03  ~   :  ¼­¿ï´ëÇб³ ´ëÇпø ÀÇÇаú ¹Ú»ç°úÁ¤

°æ·Â

more
  • 2011 .03  ~  2012 .02  :  ¼­¿ï´ëÇб³º´¿ø ÀÎÅÏ
  • 2012 .03  ~  2016 .02  :  ¼­¿ï´ëÇб³º´¿ø ¿Ü°ú Àü°øÀÇ
  • 2019 .05  ~  2020 .11  :  ¼­¿ï´ëÇб³º´¿ø °£´ãÃé¿Ü°ú ÀÓ»ó°­»ç
  • 2020 .12  ~  2021 .08  :  ¼­¿ï´ëÇб³º´¿ø °£´ãÃé¿Ü°ú Áø·á±³¼ö
  • 2021 .09  ~   :  °í·Á´ëÇб³ ±¸·Îº´¿ø ÀÓ»óÁ¶±³¼ö

ÇÐȸȰµ¿

more
  •  ~   :  ´ëÇÑ¿Ü°úÇÐȸ Á¤È¸¿ø
  •  ~   :  Çѱ¹°£´ãÃé¿Ü°úÇÐȸ Æò»ýȸ¿ø
  •  ~   :  Çѱ¹ÃéÀå¿Ü°úÇÐȸ Æò»ýȸ¿ø
  •  ~   :  ´ëÇѳ»½Ã°æº¹°­°æÇÐȸ Á¤È¸¿ø
  •  ~   :  ¼¼°è°£´ãÃé¿Ü°úÇÐȸ (IHPBA) Á¤È¸¿ø

³í¹®

more
  • [SCIE] (Endocrine Function Impairment After Distal Pancreatectomy: Incidence and Related Factors)
  • [SCIE] (Prevention of pancreatic fistula using polyethylene glycolic acid mesh reinforcement around pancreatojejunostomy: the propensity score-matched analysis)
  • [SCIE] (Prediction of Pancreatic Fistula After Distal Pancreatectomy Based on Cross-Sectional Images)
  • [SCIE] (Long-term outcomes and recurrence patterns of standard versus extended pancreatectomy for pancreatic head cancer: a multicenter prospective randomized controlled study)
  • [SCIE] (Clinicopathologic and survival differences in younger patients with pancreatic ductal adenocarcinoma-A propensity score-matched comparative analysis)
  • [SCIE] (Influence of preoperative nutritional status on clinical outcomes after pancreatoduodenectomy)
  • [SCIE] (Prognostic predictability of the new American Joint Committee on Cancer 8th staging system for distal bile duct cancer: limited usefulness compared with the 7th staging system)
  • [SCIE] (Clinical validation of the 2017 international consensus guidelines on intraductal papillary mucinous neoplasm of the pancreas)
  • [SCIE] (Clinical validation of scoring systems of postoperative pancreatic fistula after pancreatoduodenectomy: applicability to Eastern cohorts?)
  • [SCIE] (Proposal of the minimal number of retrieved regional lymph nodes for accurate staging of distal bile duct cancer and clinical validation of the three-tier lymph node staging system (AJCC 8th edition))
  • [SCIE] (Short- and long-term outcomes of pancreaticoduodenectomy in elderly patients with periampullary cancer)
  • [SCIE] (Clinicoradiological features of resected serous cystic neoplasms according to morphological subtype and preoperative tentative diagnosis: can radiological characteristics distinguish serous cystic neoplasms from other lesions?)
  • [SCIE] (A comparison of outcomes in patients with intracholecystic papillary neoplasms or conventional adenocarcinomas of the gallbladder)
  • [SCIE] (Risk prediction for malignant intraductal papillary mucinous neoplasm of the pancreas: logistic regression versus machine learning)
  • [SCIE] (Development and External Validation of Survival Prediction Model for Pancreatic Cancer Using Two Nationwide Database: Surveillance, Epidemiology and End Results (SEER) and Korea Tumor Registry System-Biliary Pancreas (KOTUS-BP))
  • [SCIE] (A retrospective multicentre study on the evaluation of perioperative outcomes of single-port robotic cholecystectomy comparing the Xi and SP versions of the da Vinci robotic surgical system)
  • [SCIE] (Limits of serum carcinoembryonic antigen and carbohydrate antigen 19-9 as the diagnosis of gallbladder cancer)
  • [SCIE] (Radiological tumour invasion of splenic artery or vein in patients with pancreatic body or tail adenocarcinoma and effect on recurrence and survival)

ÃÖÁ¾¼öÁ¤ÀÏ : 2023.05.08